Treating Metastatic Breast Cancer After the First-Line Setting: What to Do Next?

Treating Metastatic Breast Cancer After the First-Line Setting: What to Do Next?

ReachMD Healthcare Image
RestartResume

How can we treat patients with metastatic breast cancer who progress after first-line treatment with a CDK4/6 inhibitor?

  • Overview

    The treatment landscape for metastatic breast cancer is rapidly evolving. With all of these new advancements and research, it can be helpful to review the available treatment options and best practices for selecting an approach after treatment with a CDK4/6 inhibitor has failed. That’s why Dr. Charles Turck discusses how we can treat patients with metastatic breast cancer in the second- and third-line setting with Dr. Hope Rugo, who’s a Professor of Medicine in the Division of Hematology and Oncology at the University of California San Francisco Hellen Diller Family Comprehensive Cancer Center.

Facebook Comments

NEW FEATURES:

Register

We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free